These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7564108)

  • 1. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
    Quigg RJ; Morgan BP; Holers VM; Adler S; Sneed AE; Lo CF
    Kidney Int; 1995 Aug; 48(2):412-21. PubMed ID: 7564108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis.
    Quigg RJ; Holers VM; Morgan BP; Sneed AE
    J Immunol; 1995 Apr; 154(7):3437-43. PubMed ID: 7534798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.
    Caragine TA; Imai M; Frey AB; Tomlinson S
    Blood; 2002 Nov; 100(9):3304-10. PubMed ID: 12384431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
    Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
    Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Crry protects mesangial cells from complement-mediated injury.
    Nangaku M; Quigg RJ; Shankland SJ; Okada N; Johnson RJ; Couser WG
    J Am Soc Nephrol; 1997 Feb; 8(2):223-33. PubMed ID: 9048341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.
    Quigg RJ; He C; Hack BK; Alexander JJ; Morgan BP
    Immunology; 2000 Jan; 99(1):46-53. PubMed ID: 10651940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
    Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
    J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
    Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y
    Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).
    Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS
    J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.
    Caragine TA; Okada N; Frey AB; Tomlinson S
    Cancer Res; 2002 Feb; 62(4):1110-5. PubMed ID: 11861390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
    Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
    Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of rat glomerular epithelial cell complement receptors.
    Quigg RJ; Sneed AE
    J Am Soc Nephrol; 1994 May; 4(11):1912-9. PubMed ID: 7919144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B virus X protein upregulates the expression of CD59 and Crry in mouse podocytes].
    Yin XL; Zhou JH
    Zhonghua Er Ke Za Zhi; 2010 Dec; 48(12):934-8. PubMed ID: 21215189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfected CD59 protects mesangial cells from injury induced by antibody and complement.
    Nangaku M; Meek RL; Pippin J; Gordon KL; Morgan BP; Johnson RJ; Couser WG
    Kidney Int; 1996 Jul; 50(1):257-66. PubMed ID: 8807596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.
    Hori Y; Yamada K; Hanafusa N; Okuda T; Okada N; Miyata T; Couser WG; Kurokawa K; Fujita T; Nangaku M
    Kidney Int; 1999 Dec; 56(6):2096-106. PubMed ID: 10594785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement regulatory proteins and selective vulnerability of neurons to lysis on exposure to acetylcholinesterase antibody.
    Tang H; Brimijoin S
    J Neuroimmunol; 2001 Apr; 115(1-2):53-63. PubMed ID: 11282154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.